Alvotech Switches CEO And Takes COO From Teva

Founder Wessman Will Replace Levick As CEO, While Fridriksdottir Joins Firm From January

Major leadership changes are being made at the top of Alvotech, with founder Robert Wessman stepping in to replace Mark Levick as CEO at the same time as Teva’s former head of global R&D, Hafrun Fridriksdottir, becomes COO of the biosimilars developer.

Leader change wooden blocks
Changes are being made at the top of Alvotech’s leadership structure • Source: Shutterstock

The start of 2023 will see major changes at the top of Alvotech’s management structure, after the company announced that chief executive officer Mark Levick would be stepping down, to be replaced in the CEO role by founder and executive chairman Robert Wessman.

At the same time, former Teva head of global R&DHafrun Fridriksdottir will join the biosimilars specialist as chief operating officer....

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Leadership

Wagner Adds Germany To Role As Stada Simplifies Structure

Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.

ADHD

This is regarding ADHD.

test

More from Generics Bulletin

GB-Business-Free-Podcast-The Secret to Walking More: It’s Not Counting Steps - Clone

 
• By 

We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.